Paul Jackson

机构：Johnson & Johnson (United States), Janssen (Belgium) · ORCID：0009-0009-4160-8489

发表论文 124 篇 · 总被引 2655 次 · h-index 27

代表论文

• Targeting de novo purine biosynthesis for tuberculosis treatment (2025 · Nature · 被引 24)
• Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 (2024 · Journal of Medicinal Chemistry · 被引 9)
• A Novel Small Molecule Allosteric Inhibitor of IL-17A from a DNA-Encoded Library (2025 · ACS Medicinal Chemistry Letters · 被引 7)
• Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4 (2025 · Journal of Medicinal Chemistry · 被引 7)
• Exploration and characterization of the antimalarial activity of cyclopropyl carboxamides that target the mitochondrial protein, cytochrome b (2024 · European Journal of Medicinal Chemistry · 被引 5)
• Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4 (2024 · ChemMedChem · 被引 5)